A First-in-Human, Phase 1 Study of JAB-3312 in Adult Patients With Advanced Solid Tumors
Jacobio Pharmaceuticals Co., Ltd.
Jacobio Pharmaceuticals Co., Ltd.
MacroGenics
Allist Pharmaceuticals, Inc.
Sumitomo Pharma America, Inc.
University Hospital Plymouth NHS Trust
Sumitomo Pharma America, Inc.
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
St. Olavs Hospital
Oryx GmbH & Co. KG
AstraZeneca
Halozyme Therapeutics
Celgene
Precision Biologics, Inc
Astellas Pharma Inc
Radboud University Medical Center
Silence Therapeutics GmbH
University of Florida
Astellas Pharma Inc
Mayo Clinic
Pfizer